Now showing items 1-1 of 1
Phase II Trial of Suramin in Patients with Metastatic Renal Cell Carcinoma
(Kluwer Academic Publishers; Springer Science+Business Media, 1999-05)
This study was conducted to assess the efficacy and toxicity of suramin administered using a fixed dose schedule in patients with advanced renal cell carcinoma. Fourteen eligible patients with advanced renal cell carcinoma ...